|
KR102508166B1
(ko)
|
2014-04-10 |
2023-03-13 |
시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 |
세포 면역요법을 위한 방법 및 조성물
|
|
US10428305B2
(en)
|
2014-05-15 |
2019-10-01 |
National University Of Singapore |
Modified natural killer cells that express IL15 and uses thereof
|
|
BR112017013690A2
(pt)
|
2014-12-24 |
2018-03-06 |
Ucl Business Plc |
célula
|
|
GB201503742D0
(en)
*
|
2015-03-05 |
2015-04-22 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
MX2018001568A
(es)
|
2015-08-07 |
2019-04-25 |
Seattle Children´S Hospital Dba Seattle Children´S Res Institute |
Celulas t biespecificas de receptor quimerico de antigeno (car) para focalizacion a tumores solidos.
|
|
US9681109B2
(en)
*
|
2015-08-20 |
2017-06-13 |
Qualcomm Incorporated |
Systems and methods for configurable demodulation
|
|
US11446398B2
(en)
|
2016-04-11 |
2022-09-20 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
|
WO2018182511A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
AU2018246235B2
(en)
*
|
2017-03-27 |
2023-12-21 |
National University Of Singapore |
Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
CN107098981B
(zh)
*
|
2017-06-29 |
2020-05-01 |
青岛麦迪赛斯医疗技术有限公司 |
一种靶向cd19的嵌合抗原受体修饰的t淋巴细胞
|
|
EP3662055A1
(en)
*
|
2017-08-02 |
2020-06-10 |
Autolus Limited |
Cells expressing a chimeric antigen receptor or engineered tcr and comprising a nucleotide sequence which is selectively expressed
|
|
JP7089806B2
(ja)
*
|
2017-12-06 |
2022-06-23 |
アブクロン・インコーポレイテッド |
悪性ｂ細胞を特異的に認知する抗体またはその抗原結合断片、これを含むキメラ抗原受容体及びその用途
|
|
CN107903326B
(zh)
*
|
2018-01-02 |
2020-06-30 |
广东省人民医院(广东省医学科学院) |
包含C3aR胞内结构域的嵌合抗原受体、慢病毒载体、表达细胞及药物
|
|
CN108047332B
(zh)
*
|
2018-01-15 |
2021-08-24 |
阿思科力(苏州)生物科技有限公司 |
以cd19为靶点的特异性抗体、car-nk细胞及其制备和应用
|
|
US12258381B2
(en)
|
2018-02-09 |
2025-03-25 |
National University Of Singapore |
Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
EP3757133A4
(en)
*
|
2018-02-11 |
2021-12-01 |
Jiangsu Hengrui Medicine Co., Ltd. |
ISOLATED ANTIGENIC CHEMICAL RECEPTOR, MODIFIED T LYMPHOCYTE INCLUDING IT AND ASSOCIATED USE
|
|
WO2019193476A1
(en)
|
2018-04-02 |
2019-10-10 |
National University Of Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
CN116836297A
(zh)
*
|
2018-04-12 |
2023-10-03 |
上海赛比曼生物科技有限公司 |
靶向bcma的嵌合抗原受体及其制法和应用
|
|
GB201807870D0
(en)
|
2018-05-15 |
2018-06-27 |
Autolus Ltd |
A CD79-specific chimeric antigen receptor
|
|
US11963981B2
(en)
|
2018-05-15 |
2024-04-23 |
Autolus Limited |
Chimeric antigen receptor
|
|
CN108794642A
(zh)
*
|
2018-07-05 |
2018-11-13 |
宁波安诺柏德生物医药科技有限公司 |
一种嵌合抗原细胞受体及其应用
|
|
CN110819678A
(zh)
*
|
2018-08-07 |
2020-02-21 |
上海恒润达生生物科技有限公司 |
一种评估cart细胞有效性的方法
|
|
CN110850068B
(zh)
*
|
2018-08-21 |
2023-08-15 |
上海恒润达生生物科技股份有限公司 |
一种嵌合抗原受体亲和力检测方法
|
|
US12486514B2
(en)
|
2018-08-29 |
2025-12-02 |
National University Of Singapore |
Method to specifically stimulate survival and expansion of genetically-modified immune cells
|
|
JP7458382B2
(ja)
*
|
2018-09-27 |
2024-03-29 |
オートラス リミテッド |
キメラ抗原受容体
|
|
GB201816522D0
(en)
|
2018-10-10 |
2018-11-28 |
Autolus Ltd |
Methods and reagents for analysing nucleic acids from single cells
|
|
WO2020092736A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
US12264189B2
(en)
|
2018-10-31 |
2025-04-01 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
AU2019372673A1
(en)
|
2018-11-01 |
2021-05-27 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for T cell engineering
|
|
CN109468282B
(zh)
*
|
2018-11-22 |
2019-06-18 |
青岛协和华美医学诊断技术有限公司 |
一种靶向cd19的嵌合抗原受体t细胞的制备方法及应用
|
|
CN109734813B
(zh)
*
|
2019-01-28 |
2022-06-17 |
广东昭泰体内生物医药科技有限公司 |
一种嵌合抗原受体及其应用
|
|
JP6821230B2
(ja)
*
|
2019-02-04 |
2021-01-27 |
国立大学法人愛媛大学 |
ＣＡＲライブラリおよびｓｃＦｖの製造方法
|
|
US12419913B2
(en)
|
2019-02-08 |
2025-09-23 |
Dna Twopointo, Inc. |
Modification of CAR-T cells
|
|
EP3924386A4
(en)
|
2019-02-13 |
2023-01-04 |
The Brigham & Women's Hospital, Inc. |
ADDRESSIN-TYPE ANTI-PERIPHERAL LYMPHATIC NODE ANTIBODIES AND THEIR USES
|
|
CN118546959A
(zh)
|
2019-03-05 |
2024-08-27 |
恩卡尔塔公司 |
Cd19定向性嵌合抗原受体及其在免疫疗法中的用途
|
|
EP3934666A1
(en)
|
2019-03-08 |
2022-01-12 |
Autolus Limited |
Compositions and methods comprising engineered chimeric antigen receptor and modulator of car
|
|
GB201903237D0
(en)
|
2019-03-08 |
2019-04-24 |
Autolus Ltd |
Method
|
|
AU2020288829A1
(en)
*
|
2019-06-04 |
2021-12-02 |
Nkarta, Inc. |
Combinations of engineered natural killer cells and engineered T cells for immunotherapy
|
|
BR112021026832A2
(pt)
|
2019-07-02 |
2022-05-10 |
Hutchinson Fred Cancer Res |
Vetores ad35 recombinantes e aprimoramentos da terapia gênica relacionada
|
|
CN114286683B
(zh)
*
|
2019-07-17 |
2024-10-01 |
新加坡国立大学 |
由免疫细胞合成和分泌的功能性结合物
|
|
JP7723420B2
(ja)
*
|
2019-08-28 |
2025-08-14 |
キングス・カレッジ・ロンドン |
Ｂ細胞標的化並列ＣＡＲ（ｐＣＡＲ）治療的薬剤
|
|
CA3164666A1
(en)
*
|
2020-01-13 |
2021-07-22 |
Kanya Lakshmi RAJANGAM |
Bcma-directed cellular immunotherapy compositions and methods
|
|
CN115484978A
(zh)
|
2020-03-05 |
2022-12-16 |
尼奥克斯医疗有限公司 |
使用免疫细胞治疗癌症的方法和组合物
|
|
CN113402612A
(zh)
*
|
2020-03-17 |
2021-09-17 |
西比曼生物科技（香港）有限公司 |
靶向cd19和cd20的联合嵌合抗原受体及其应用
|
|
GB202005216D0
(en)
|
2020-04-08 |
2020-05-20 |
Autolus Ltd |
Cell
|
|
JP2023525049A
(ja)
*
|
2020-05-08 |
2023-06-14 |
シアトル・チルドレンズ・ホスピタル・ドゥーイング／ビジネス／アズ・シアトル・チルドレンズ・リサーチ・インスティテュート |
ナチュラルキラー細胞を標的とするキメラ抗原受容体（ｃａｒ）
|
|
WO2022031597A1
(en)
|
2020-08-03 |
2022-02-10 |
Kyverna Therapeutics, Inc. |
Methods of producing t regulatory cells, methods of transducing t cells, and uses of the same
|
|
WO2022072515A1
(en)
*
|
2020-09-29 |
2022-04-07 |
Washington University |
Methods to determine risk of neurotoxicity
|
|
AU2021401052A1
(en)
|
2020-12-18 |
2023-06-22 |
Century Therapeutics, Inc. |
Chimeric antigen receptor systems with adaptable receptor specificity
|
|
US20240316199A1
(en)
|
2020-12-30 |
2024-09-26 |
Alaunos Therapeutics, Inc. |
Recombinant Vectors Comprising Polycistronic Expression Cassettes and Methods of Use Thereof
|
|
WO2022165419A1
(en)
|
2021-02-01 |
2022-08-04 |
Kyverna Therapeutics, Inc. |
Methods for increasing t-cell function
|
|
CN117545771A
(zh)
*
|
2021-04-08 |
2024-02-09 |
克莱格医学有限公司 |
细胞免疫治疗的应用
|
|
EP4522204A1
(en)
|
2022-05-11 |
2025-03-19 |
Autolus Limited |
Cd19/22 car t-cell treatment of high risk or relapsed pediatric acute lymphoblastic leukemia
|
|
CN117088975B
(zh)
*
|
2022-05-11 |
2024-06-25 |
东莞市朋志生物科技有限公司 |
抗白蛋白抗体、检测白蛋白的试剂和试剂盒
|
|
CN116253794B
(zh)
*
|
2022-08-19 |
2025-04-04 |
首都医科大学宣武医院 |
一种用于car-t细胞调控的抗体及其应用
|
|
EP4626447A1
(en)
|
2023-03-31 |
2025-10-08 |
AbelZeta Inc. |
Bispecific chimeric antigen receptors targeting cd20 and bcma
|
|
WO2024246526A1
(en)
|
2023-05-30 |
2024-12-05 |
Autolus Limited |
Cd19car t-cell treatment of relapsed/refractory b-cell acute lymphoblastic leukaemia
|
|
WO2025008642A1
(en)
|
2023-07-05 |
2025-01-09 |
Autolus Limited |
Method
|
|
CN119350497A
(zh)
*
|
2023-07-24 |
2025-01-24 |
星尘生物科技(上海)有限公司 |
人源化抗cd19单链可变区片段及其用途
|
|
GB202316184D0
(en)
|
2023-10-23 |
2023-12-06 |
Autolus Ltd |
Method
|
|
WO2025088308A1
(en)
|
2023-10-23 |
2025-05-01 |
Autolus Limited |
Products and methods for treating autoimmune diseases
|
|
EP4574838A1
(en)
|
2023-12-21 |
2025-06-25 |
Vilnius University |
Chimeric antigen receptor (car) with enhanced recruitment of signaling partners
|
|
GB202403564D0
(en)
|
2024-03-12 |
2024-04-24 |
Autolus Ltd |
Method
|
|
WO2025215360A1
(en)
|
2024-04-09 |
2025-10-16 |
Autolus Limited |
Method
|